Stem Cells Improve Outcomes in Ischemic HF

ACC Conference Reporter

ACC.16 | CHICAGO — Autologous bone marrow stem cell injections into the heart appeared to improve outcomes in heart failure from ischemic dilated cardiomyopathy, a phase IIb trial showed. Read More >>>

Keywords: ACC Annual Scientific Session


< Back to Listings